Related Experiment Videos
Low frequency of MECP2 mutations in mentally retarded males
Helger G Yntema1, Tjitske Kleefstra, Astrid R Oudakker
1Department of Human Genetics, University Medical Center, Nijmegen, The Netherlands. H.Yntema@antrg.azn.nl
Abstract:
A high frequency of mutations in the methyl CpG-binding protein 2 (MECP2) gene has recently been reported in males with nonspecific X-linked mental retardation. The results of this previous study suggested that the frequency of MECP2 mutations in the mentally retarded population was comparable to that of CGG expansions in FMR1. In view of these data, we performed MECP2 mutation analysis in a cohort of 475 mentally retarded males who were negative for FMR1 CGG repeat expansion. Five novel changes, detected in seven patients, were predicted to change the MECP2 coding sequence. Except for one, these changes were not found in a control population. While this result appeared to suggest a high mutation rate, this conclusion was not supported by segregation studies. Indeed, three of the five changes could be traced in unaffected male family members. For another change, segregation analysis in the family was not possible. Only one mutation, a frameshift created by a deletion of two bases, was found to be de novo. This study clearly shows the importance of segregation analysis for low frequency mutations, in order to distinguish them from rare polymorphisms. The true frequency of MECP2 mutations in the mentally retarded has probably been overestimated. Based on our data, the frequency of MECP2 mutations in mentally retarded males is 0.2% (1/475).
Insights
This study investigated methyl CpG-binding protein 2 (MECP2) gene mutations in males with mental retardation. Findings indicate the actual mutation frequency is likely lower than previously suggested, emphasizing the need for segregation analysis.
Area of Science:
- Genetics
- Neurodevelopmental Disorders
Background:
- Methyl CpG-binding protein 2 (MECP2) gene mutations are implicated in X-linked mental retardation.
- Previous studies suggested a high frequency of MECP2 mutations in the mentally retarded population.
Purpose of the Study:
- To analyze MECP2 gene mutations in a cohort of males with mental retardation, excluding Fragile X Syndrome.
- To determine the true frequency of MECP2 mutations in this population.
Main Methods:
- MECP2 mutation analysis was performed on 475 males with mental retardation, negative for FMR1 CGG repeat expansion.
- Segregation analysis was conducted within families to validate identified changes.
Main Results:
- Five novel sequence changes in MECP2 were detected in seven patients.
- Segregation studies revealed three changes in unaffected family members, and one de novo mutation.
- The confirmed MECP2 mutation frequency in this cohort was 0.2% (1/475).
Conclusions:
- The frequency of MECP2 mutations in mentally retarded males may have been overestimated.
- Segregation analysis is crucial for distinguishing true mutations from rare polymorphisms in low-frequency mutation studies.